SCHEMBL30403122

SCHEMBL30403122

COc1ccc(COc2ccc3oc(-c4cccc(Oc5ccccc5)c4)nc3c2)nc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 7/20 0.53
ALDH1A1 P00352 5/20 0.53
HPGD P15428 5/20 0.53
SMN1; SMN2 Q16637 5/20 0.53
TP53 P04637 4/20 0.53
RAB9A P51151 4/20 0.53
KDM4E B2RXH2 3/20 0.53
NPC1 O15118 3/20 0.53
NFKB1 P19838 2/20 0.53
NFKB2 Q00653 2/20 0.53
RELA Q04206 2/20 0.53
L3MBTL1 Q9Y468 2/20 0.53
GLA P06280 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
MAPT P10636 3/20 0.50
TSHR P16473 3/20 0.50
MAPK1 P28482 2/20 0.50
CASP3 P42574 2/20 0.50
SENP8 Q96LD8 1/20 0.50
SENP7 Q9BQF6 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17544797 1.00 HSD17B10 (0.53) HSD17B10ALDH1A1HPGDSMN1; SMN2TP53
SCHEMBL30402440 0.92 ALDH1A1 (0.53) HSD17B10ALDH1A1HPGDSMN1; SMN2TP53
SCHEMBL17544578 0.92 ALDH1A1 (0.53) HSD17B10ALDH1A1HPGDSMN1; SMN2TP53
SCHEMBL19428553 0.89 ALDH1A1 (0.49) HSD17B10ALDH1A1HPGDSMN1; SMN2TP53
SCHEMBL23633322 0.87 SMN1; SMN2 (0.58) HSD17B10ALDH1A1HPGDSMN1; SMN2TP53
SCHEMBL17544004 0.86 ALDH1A1 (0.49) HSD17B10ALDH1A1HPGDSMN1; SMN2TP53
SCHEMBL17544292 0.83 RAB9A (0.47) HSD17B10ALDH1A1HPGDSMN1; SMN2TP53
SCHEMBL30402927 0.83 TP53 (0.50) HSD17B10ALDH1A1HPGDSMN1; SMN2TP53
SCHEMBL17544253 0.83 TP53 (0.50) HSD17B10ALDH1A1HPGDSMN1; SMN2TP53
SCHEMBL30402349 0.83 RAB9A (0.47) HSD17B10ALDH1A1HPGDSMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12258355-B2 Probes for imaging huntingtin protein CHDI FOUNDATION, INC. (US) 2025-03-25 US disclosed
CN-116655618-A Probes for imaging huntingtin CHDI基金会股份有限公司 2023-08-29 CN disclosed
US-20230212190-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN CHDI FOUNDATION, INC. 2023-07-06 US disclosed
CN-107108534-B Probes for imaging huntingtin CHDI基金会股份有限公司 2023-05-09 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230212190-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN HTT, HYPK, HSPBP1 HSD17B10 966/4885ALDH1A1 3976/4885HPGD 2107/4885
US-12258355-B2 Probes for imaging huntingtin protein HTT, HYPK, HSPBP1 HSD17B10 966/4885ALDH1A1 3976/4885HPGD 2107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.